G01N 33/56905
Protozoa
Official title: {Protozoa}
G01N33/56905 (Protozoa) appears on 322 US grants and 388 published applications in this corpus.
Search patents in G01N- Granted patents
- 322
- Published applications
- 388
- Assignees
- 277
- Inventors
- 1,045
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 12 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 10 | 4 |
| 2002 | 9 | 14 |
| 2003 | 4 | 12 |
| 2004 | 8 | 16 |
| 2005 | 7 | 11 |
| 2006 | 7 | 23 |
| 2007 | 7 | 19 |
| 2008 | 12 | 13 |
| 2009 | 12 | 23 |
| 2010 | 13 | 23 |
| 2011 | 12 | 18 |
| 2012 | 15 | 17 |
| 2013 | 12 | 17 |
| 2014 | 17 | 23 |
| 2015 | 10 | 22 |
| 2016 | 17 | 14 |
| 2017 | 12 | 17 |
| 2018 | 13 | 16 |
| 2019 | 22 | 12 |
| 2020 | 8 | 15 |
| 2021 | 6 | 10 |
| 2022 | 5 | 10 |
| 2023 | 6 | 11 |
| 2024 | 2 | 16 |
| 2025 | 6 | 9 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Serological marker for the latent form of toxoplasmosis29 Sep 2026US 12,748,112 B2Centre Hospitalier Universitaire De Grenoble
- Landless monogastric animal production system18 Aug 2026US 12,708,106 B2Dsm IP Assets B.V.
- Velvet disease detection device, system and method18 Aug 2026US 12,710,420 B2Mote Marine Laboratory
- Diagnosis of Babesia using Babesia recombinant proteins7 Jul 2026US 12,674,803 B2ID-Fish Technology, Inc.
- Chimeric protein, method of production and use thereof, and also a nucleic acid molecule, expression cassette, expression vector, host cell, composition for the diagnosis of leishmaniasis, kit for the diagnosis of leishmaniasis and method of diagnosis of leishmaniasis in vitro3 Jun 2025US 12,320,807 B2FundaçãO Oswaldo Cruz
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Methods and Reagents for Toxoplasma Infection Diagnosis5 Mar 2026US 2026/0063633 A1
- Means for detecting schistosoma infection12 Feb 2026US 2026/0043803 A1
- Compositions and methods for detecting lymphatic filariasis23 Oct 2025US 2025/0327800 A1The United States of America, as represented by the Secretary, Dept. of Health and Human Services
- Systems and methods for airborne environmental detection and surveillance of pathogens with electrochemical analysis23 Oct 2025US 2025/0327801 A1Washington University
Most cited
By later US patents
- Immobilized antibody or antigen for immunoassay164US 4,407,943 AMillipore Corporation · 1983
- Retro-, inverso- and retro-inverso synthetic peptide analogues90US 6,261,569 B1Deakin Research Limited · 2001
- Monoclonal antibodies to a pan-malarial antigen81US 5,001,225 AGeorgetown University · 1991
- Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions47US 8,030,002 B2Curemark, LLC · 2011
- Portable rapid diagnostic test reader45US 8,916,390 B2The Regents of the University of California · 2014